Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Oncology Pharma Inc. stock logo
ONPH
Oncology Pharma
$0.00
$0.00
$0.00
$0.13
N/A0.911,709 shs4,127 shs
PVTA
(PVTA)
$0.00
$0.00
$0.00
N/AN/AN/AN/A
UCPH
(UCPH)
$0.00
$0.19
$0.19
N/AN/AN/A200 shs
VRYAF
(VRYAF)
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Oncology Pharma Inc. stock logo
ONPH
Oncology Pharma
0.00%0.00%0.00%0.00%-50.00%
UCPH
(UCPH)
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Oncology Pharma Inc. stock logo
ONPH
Oncology Pharma
N/AN/AN/AN/AN/AN/AN/AN/A
PVTA
(PVTA)
N/AN/AN/AN/AN/AN/AN/AN/A
UCPH
(UCPH)
N/AN/AN/AN/AN/AN/AN/AN/A
VRYAF
(VRYAF)
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Oncology Pharma Inc. stock logo
ONPH
Oncology Pharma
0.00
N/AN/AN/A
PVTA
(PVTA)
0.00
N/AN/AN/A
UCPH
(UCPH)
0.00
N/AN/AN/A
VRYAF
(VRYAF)
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Oncology Pharma Inc. stock logo
ONPH
Oncology Pharma
N/AN/AN/AN/AN/AN/A
PVTA
(PVTA)
N/AN/AN/AN/AN/AN/A
UCPH
(UCPH)
N/AN/AN/AN/AN/AN/A
VRYAF
(VRYAF)
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Oncology Pharma Inc. stock logo
ONPH
Oncology Pharma
N/AN/A0.00N/AN/AN/AN/AN/A
PVTA
(PVTA)
N/AN/A0.00N/AN/AN/AN/AN/AN/A
UCPH
(UCPH)
N/AN/A0.00N/AN/AN/AN/AN/AN/A
VRYAF
(VRYAF)
N/AN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Oncology Pharma Inc. stock logo
ONPH
Oncology Pharma
N/AN/AN/AN/AN/A
PVTA
(PVTA)
N/AN/AN/AN/AN/A
UCPH
(UCPH)
N/AN/AN/AN/AN/A
VRYAF
(VRYAF)
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Oncology Pharma Inc. stock logo
ONPH
Oncology Pharma
N/A
PVTA
(PVTA)
N/A
UCPH
(UCPH)
N/A
VRYAF
(VRYAF)
N/A

Insider Ownership

CompanyInsider Ownership
Oncology Pharma Inc. stock logo
ONPH
Oncology Pharma
18.00%
PVTA
(PVTA)
N/A
UCPH
(UCPH)
N/A
VRYAF
(VRYAF)
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Oncology Pharma Inc. stock logo
ONPH
Oncology Pharma
138.66 million31.70 millionNot Optionable
PVTA
(PVTA)
147,000N/AN/ANot Optionable
UCPH
(UCPH)
N/AN/AN/ANot Optionable
VRYAF
(VRYAF)
N/AN/AN/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Oncology Pharma stock logo

Oncology Pharma OTCMKTS:ONPH

$0.0001 0.00 (0.00%)
As of 12:12 PM Eastern

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

(PVTA) OTCMKTS:PVTA

Preventia, Inc, works with corporate clients through its subsidiary, Preventia Group Corp., to develop, market and distribute financial products, such as debt instruments, venture capital funds, expiration-less options, insurance products and energy futures for dematerialization and electronic trading. It operates an electronic trading platform through a third-party service provider with respect to the foregoing. As of June 30, 2012, the Company also pursued various software-related licensing and other business opportunities. As of June 30, 2012, the Company had not generated any revenue.

(VRYAF) OTCMKTS:VRYAF

ViryaNet Ltd. (ViryaNet) is a provider of software solutions for mobile workforces. It also provides professional services required to implement and support the software solutions. ViryaNet's fourth generation product suite, G4, provides Web-based solutions, which optimize the field service operations, including the creation of work orders, scheduling and dispatching field personnel, tracking equipment under warranty, managing spare parts inventory and receiving real-time reports from the field. In August 2014, ViryaNet Ltd announced that the completion of its previously announced acquisition by Verisae Inc.